ArticleDigestive diseases and sciences2026
WISP2 Overexpression Is Associated with Reduced Vasculogenic Mimicry and Epithelial-Mesenchymal Transition in Gastric Cancer.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Explainable Deep Learning of Transcriptomes Prioritizes Candidate Biomarkers With Preferential Performance in Gastric Cardia Cancer Cohorts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the association between WISP2 overexpression, vasculogenic mimicry (VM), and epithelial-mesenchymal transition (EMT) in gastric cancer.
methodsPathological specimens from 50 patients who underwent radical gastrectomy at the First Affiliated Hospital of Bengbu Medical College between February 2022 and February 2023 were analyzed. WISP2 expression and VM formation in tumor and adjacent tissues were evaluated using GEPIA database analysis and immunohistochemistry. Gastric cancer cell proliferation, migration, and invasion were assessed using CCK-8, scratch wound, and Transwell assays, respectively. Nude mouse xenograft models were established to evaluate tumor growth and VM formation in vivo. The expression of VM- and EMT-related molecules was examined by quantitative PCR and Western blotting.
resultsVM structures were observed in gastric cancer tissues, and WISP2 expression was significantly lower in VM-positive specimens compared with VM-negative specimens (P < 0.05). Overexpression of WISP2 significantly inhibited gastric cancer cell proliferation, migration, and invasion (all P < 0.05). Increased WISP2 expression was associated with suppression of EMT features and reduced VM-forming capacity (both P < 0.05). In xenograft models, tumors overexpressing WISP2 showed decreased tumor growth and reduced VM formation compared with controls (P < 0.05). Western blot analysis demonstrated that WISP2 overexpression was associated with downregulation of p-β-catenin (Ser675), total β-catenin, p-GSK-3β (Ser9), and TCF4 (P < 0.05).
conclusionWISP2 overexpression is associated with reduced vasculogenic mimicry in gastric cancer, potentially through suppression of EMT and inhibition of the Wnt/β-catenin signaling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.